[Direct positive inotropic influencing on the heart using oral spironolactone therapy].
D000284:Administration, Oral; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008297:Male; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*
D002245:Carbon Dioxide; D013148:Spironolactone; D010100:Oxygen
Direkte positiv inotrope Herzwirkung durch orale Spironolacton-Behandlung.